$149M&A Pre-Acquisition Check β€” Protect millions before you sign. Instant report.Run a Check β†’
Services background
Our Services

End-to-End Expertise
Across Every Stage.

From pharmaceutical drug design to federal contract acquisition and organizational wellness β€” Bridge BioHealth delivers integrated solutions that reduce cost, accelerate timelines, and build lasting value.

Biotech Consulting

Drug Design &
Regulatory Strategy

We provide strategic guidance across the full pharmaceutical development lifecycle β€” from early-stage drug design through regulatory submission. Our team reduces friction, cuts costs, and accelerates your path to clinical validation.

Biotech Consulting
50+
Drug Programs Advised
30%
Avg. Timeline Reduction
$2M+
CRO Savings Negotiated
15+
IND Applications Supported

Pharmaceutical Drug Design

Strategic guidance on small molecule and biologic drug design, target identification, lead optimization, and structure-activity relationship (SAR) analysis.

Drug Screening Strategy

Design and oversight of high-throughput screening campaigns, assay development, hit-to-lead progression, and compound library curation.

Multi-Omics Data Integration

Integrating genomics, proteomics, transcriptomics, and metabolomics data to identify biomarkers, drug targets, and patient stratification strategies.

Regulatory Pathway Navigation

Expert guidance on IND applications, FDA pre-submission meetings, clinical trial design, and NDA/BLA submission strategy.

CRO Outsourcing Strategy

Identifying, evaluating, and negotiating with contract research organizations. We handle RFP development, vendor selection, and contract negotiation.

CRO Referral Network

Access to our curated network of vetted CROs across preclinical, clinical, and manufacturing stages β€” matched to your specific program needs.

Go-to-Market Strategy

Comprehensive GTM planning for biotech products and services β€” market sizing, competitive positioning, pricing strategy, and launch execution.

Operational Scaling

Building scalable operational frameworks for growing biotech companies β€” process optimization, team structure, KPI systems, and growth infrastructure.

Federal Contract Acquisition

End-to-end support for SBIR/STTR grants, NIH contracts, DoD programs, and other federal funding opportunities β€” from application to award.

Tech-Forward Infrastructure

Implementing modern, secure, and scalable technology infrastructure β€” data management, cloud systems, and digital transformation for biotech operations.

Investor Readiness

Preparing your company for VC, PE, or strategic investment β€” financial modeling, pitch deck development, due diligence preparation, and investor introductions.

Compliance & IP Strategy

Navigating IP protection, licensing strategy, and regulatory compliance to ensure your business operations are commercially viable and legally sound.

Business Consulting

MBA-Led Growth &
Federal Contracting

Our MBA-led consulting team brings Fortune 500 strategic thinking to the biotech world. We help startups and established companies build investment-ready operations, win federal contracts, and scale with confidence.

Business Consulting
15+
Federal Contracts Won
$8M+
Funding Secured
25+
Startups Scaled
3x
Avg. Revenue Growth
Health Coaching

Evidence-Based
Wellness Programs

Peak scientific performance starts with human health. We empower individuals and organizations with evidence-based wellness strategies that reduce burnout, improve cognitive performance, and build sustainable health cultures.

Health Coaching
500+
Individuals Coached
40+
Organizations Served
28%
Avg. Burnout Reduction
4.9/5
Client Satisfaction

Individual Health Coaching

Personalized, evidence-based wellness programs for scientists, executives, and healthcare professionals β€” addressing burnout, performance, and long-term health.

Organizational Wellness Programs

Company-wide wellness initiatives designed for biotech and pharma teams β€” improving productivity, reducing turnover, and building resilient organizational culture.

Clinical Validation Support

Reducing friction in clinical validation pipelines through evidence-based protocol design, patient engagement strategies, and outcome measurement frameworks.

Stress & Burnout Prevention

Targeted programs for high-stress research environments β€” mindfulness-based interventions, workload optimization, and sustainable performance strategies.

Nutrition & Lifestyle Medicine

Science-backed nutrition and lifestyle interventions grounded in peer-reviewed research β€” tailored to individual biomarkers and health goals.

Wellness ROI Measurement

Quantifying the business impact of wellness programs β€” absenteeism reduction, productivity metrics, and healthcare cost savings analysis.

Proven Results

Case Studies & Success Metrics

Real outcomes from real engagements. Every number is verified. Every story is a client who trusted us with something that mattered.

$8M+
Funding Secured for Clients
50+
Drug Programs Advised
15+
Federal Contracts Won
4.9/5
Average Client Rating
From Hit Compound to IND in 14 Months
IND Filing
Biotech Consulting

From Hit Compound to IND in 14 Months

Oncology Biotech Startup β€” Series A

14mo
IND Timeline
0
FDA Clinical Holds
32%
Cost vs. Single CRO
$1.2M
CRO Savings

Challenge: A Series A oncology startup had a promising kinase inhibitor with strong in vitro data but no regulatory roadmap, no CRO relationships, and a board demanding IND submission within 18 months.

Multi-Omics Biomarker Discovery for Phase II Stratification
CRO Strategy
Biotech Consulting

Multi-Omics Biomarker Discovery for Phase II Stratification

Mid-Stage Pharma β€” CNS Program

7-gene
Biomarker Panel
+40%
Enrollment Rate
$45M
Valuation Uplift
3mo
Discovery Timeline

Challenge: A CNS program entering Phase II had no validated biomarker strategy. Investor pressure demanded a precision medicine angle to differentiate from competitors and justify premium pricing.

$3.2M SBIR Phase II Award β€” First Attempt
Federal Contracts
Business Consulting

$3.2M SBIR Phase II Award β€” First Attempt

Diagnostics Startup β€” Pre-Revenue

$3.2M
SBIR Phase II Award
1st
Submission Success
$1.1M
Phase IIB Bridge
98/100
Reviewer Score

Challenge: A diagnostics startup with strong IP but zero federal contracting experience. They had missed two prior SBIR cycles due to weak commercialization narratives and budget justifications.

0 to $2.4M ARR in 11 Months β€” CRO Services Launch
Go-to-Market
Business Consulting

0 to $2.4M ARR in 11 Months β€” CRO Services Launch

Specialty CRO β€” Toxicology Focus

$2.4M
ARR in 11 Months
3x
Revenue Growth
4
Accelerator Partnerships
$800K
Inbound Pipeline

Challenge: A specialty toxicology CRO had world-class capabilities but no marketing infrastructure, no sales process, and relied entirely on word-of-mouth. Revenue had plateaued for 3 consecutive years.

28% Burnout Reduction Across 120-Person Biotech Team
Organizational Wellness
Health Coaching

28% Burnout Reduction Across 120-Person Biotech Team

Clinical-Stage Biotech β€” 120 Employees

28%
Burnout Reduction
9%
Turnover (from 22%)
$1.1M
Retention Savings
4.8/5
Program Rating

Challenge: A clinical-stage biotech was losing senior scientists to burnout at an alarming rate. Turnover cost was estimated at $1.8M annually. HR had tried standard EAP programs with no measurable impact.

CEO Performance Optimization β€” Pre-Series B
Executive Coaching
Health Coaching

CEO Performance Optimization β€” Pre-Series B

Biotech CEO β€” Series A, 45 Employees

60%
Cognitive Clarity Gain
$28M
Series B Closed
90 days
Program Duration
100%
Goal Achievement

Challenge: A biotech CEO preparing for a $25M Series B raise was experiencing severe cognitive fatigue, decision paralysis, and sleep disruption. Board confidence was wavering 6 months before the raise.

Your Story Could Be Next

Ready to Build Your
Success Story?

Every case study started with a single conversation. Book a free discovery call or ask Zawadi to find the right service for your challenge.

View Pricing
Client Voices

What Our Clients Say

From IND filings to Series B closes β€” hear directly from the scientists, founders, and executives who trusted Bridge BioHealth with their most critical challenges.

Biotech Consulting

Bridge BioHealth designed our entire IND-enabling package from scratch. Their CRO negotiation strategy alone saved us $900K and 4 months. I've worked with big-name consultancies β€” none come close to this level of scientific depth combined with real operational execution.

$900K saved, 4 months faster
PN
Dr. Priya Nair
CSO, Luminos Therapeutics
Business Consulting

We had tried twice to win an SBIR Phase II and failed both times. Bridge BioHealth rebuilt our entire application β€” the commercialization narrative, budget justification, technical approach. First submission after working with them: $3.2M award. The ROI on their consulting fee was 40x.

$3.2M SBIR on first attempt
MW
Marcus Webb
CEO, Apex Diagnostics
Health Coaching

We were hemorrhaging senior scientists. Turnover was at 22% and morale was in freefall. Bridge BioHealth's wellness program wasn't generic HR fluff β€” it was evidence-based, individualized, and measurable. Burnout dropped 28%, turnover fell to 9%. We saved over a million dollars in year one.

28% burnout reduction, $1.1M saved
AO
Dr. Amara Osei
VP People & Culture, GenVault Bio
Biotech Consulting

Their regulatory strategy team is exceptional. Pre-IND meeting prep was thorough, the FDA briefing document was flawless, and we cleared with zero clinical holds. For a first-time IND filer, having Bridge BioHealth in your corner is the difference between success and a complete hold.

Zero FDA clinical holds
LH
Dr. Lena Hoffmann
Director of Regulatory Affairs, BioNorth
Business Consulting

We had world-class toxicology capabilities and zero commercial infrastructure. Bridge BioHealth built our entire GTM engine β€” ICP, outbound playbook, pricing, accelerator partnerships. $2.4M ARR in 11 months. I genuinely didn't think that was possible. They proved me wrong.

$2.4M ARR in 11 months
YF
Yolanda Ferreira
Founder, ClearPath CRO
Health Coaching

I was 6 months from a $25M Series B raise and running on empty. The executive health program Bridge BioHealth designed for me was transformative β€” sleep, nutrition, cognitive performance, all evidence-based. I closed the round at $28M above target. I credit a significant part of that to being at my best.

$28M Series B closed above target
RM
Dr. Raj Mehta
CEO, Vertex Oncology
All testimonials are from verified clients
4.9/5 average rating across all services
95% client retention rate

Ready to Get Started?

Whether you need a single service or an integrated strategy across all three pillars β€” we're ready to bridge the gap for your organization.

Talk with Us